PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 4ZG1

#CDRs = 4; #Clusters = 4.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
A	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	61.5	H1	13	H1-13-5	11	AASGSTFGIRTMG	BBBEBAAABABBB
A	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	66.7	H2	9	H2-9-1	8	IISSGGSTD	BBBAALBBB
A	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H3	11	H3-11-*	-1	NARVGITMLAH	BBBBEABBABB
A	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	6	RDNAKNTV	BBAAALBB
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	61.5	H1	13	H1-13-5	10	AASGSTFGIRTMG	BBBEBAAABABBB
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	66.7	H2	9	H2-9-1	8	IISSGGSTD	BBBAALBBB
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H3	11	H3-11-*	-1	NARVGITMLAH	BBBBEABBABB
B	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	6	RDNAKNTV	BBAAALBB
C	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	61.5	H1	13	H1-13-5	10	AASGSTFGIRTMG	BBBEBAAABABBB
C	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	66.7	H2	9	H2-9-1	8	IISSGGSTD	BBBAALBBB
C	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H3	11	H3-11-*	-1	NARVGITMLAH	BBBBEABBABB
C	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	6	RDNAKNTV	BBAAALBB
D	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	61.5	H1	13	H1-13-5	10	AASGSTFGIRTMG	BBBEBAAABABBB
D	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	66.7	H2	9	H2-9-1	7	IISSGGSTD	BBBAALBBB
D	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H3	11	H3-11-*	-1	NARVGITMLAH	BBBBEABBABB
D	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	5	RDNAKNTV	BBAAALBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	61.5	H1	13	H1-13-5	10	AASGSTFGIRTMG	BBBEBAAABABBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	66.7	H2	9	H2-9-1	9	IISSGGSTD	BBBAALBBB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H3	11	H3-11-*	-1	NARVGITMLAH	BBBBEABBABB
E	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	5	RDNAKNTV	BBAAALBB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	61.5	H1	13	H1-13-5	11	AASGSTFGIRTMG	BBBEBAAABABBB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	66.7	H2	9	H2-9-1	8	IISSGGSTD	BBBAALBBB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H3	11	H3-11-*	-1	NARVGITMLAH	BBBBEABBABB
F	heavy	Lama.glama	La_IGHV1S3*01_VHH	93.2	La_IGHV1S3*01_VHH	100.0	H4	8	H4-8-1	5	RDNAKNTV	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022